D2P vs ChestView US

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

D2P

by 3D Systems

ChestView US

by Gleamer SAS

AI Verdict

Tool A focuses on transforming 2D medical images into 3D anatomical models for advanced visualization, surgical planning, and 3D printing, utilizing deep learning for segmentation. In contrast, Tool B is an AI-powered Computer-Assisted Detection (CADe) software specifically designed to assist radiologists in detecting and localizing various pathologies on chest X-rays. While both operate in the radiology and imaging AI space, their core functionalities and end goals are distinct, serving different stages and needs within the medical imaging workflow.

Choose D2P if…

Choose D2P if your primary need is to convert 2D medical imaging data into highly accurate 3D digital anatomical models for advanced surgical planning, patient-specific device creation, or educational purposes. This tool is ideal for specialties like neurosurgery and orthopedics that require precise 3D representations for complex procedures and the ability to 3D print anatomical guides or models.

View D2P →

Choose ChestView US if…

Choose ChestView US if you need an AI-powered computer-assisted detection (CADe) solution to rapidly and accurately identify common pathologies on chest X-rays, especially in high-volume clinical settings such as emergency departments. This software is best suited for radiologists and emergency medicine physicians aiming to reduce reading times, prioritize critical cases, and enhance diagnostic accuracy for conditions like pneumothorax, pleural effusion, and pulmonary nodules.

View ChestView US →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	D2P	ChestView US
Pricing	Contact for pricing	Unknown
Deployment	Stand-alone modular software package (workstation-based)	Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

D2P

D2P offers a comprehensive, workstation-based suite that consolidates all 3D model preparation steps, minimizing the need for technical expertise and easing adoption for complex tasks. Its intuitive editing tools and instant VR visualization provide a rich, interactive user experience for surgical planning and model creation.

Clinical Value

ChestView US

Both tools are FDA-cleared and provide significant clinical value. However, ChestView US demonstrates more direct and quantifiable clinical benefits through studies showing increased detection rates for multiple pathologies (e.g., 26.2% for pneumothorax) and a significant reduction in chest X-ray reading times (31%).

Pricing & Value

Tie

Neither D2P nor ChestView US provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. While both offer clear value propositions in their respective domains, the lack of pricing transparency results in a tie for this dimension.

Enterprise Readiness

ChestView US

ChestView US is explicitly stated as HIPAA compliant and has a Business Associate Agreement (BAA), which are crucial for healthcare enterprise adoption. Its flexible deployment options (cloud, on-premise, virtualized) also offer greater adaptability to diverse IT infrastructures compared to D2P's workstation-based deployment.

Innovation

D2P

While both leverage AI/deep learning, D2P stands out with its integration of 'industry-first Volume Virtual Reality (VR) technology' for instant visualization of medical datasets. This offers a novel and advanced way to interact with 3D anatomical models, pushing the boundaries of surgical planning and visualization.

Support & Docs

D2P

3D Systems provides explicit documentation for D2P, including an installation guide and user manual, along with dedicated healthcare customer service contacts and consulting services. While Gleamer mentions support for ChestView US, the specific details regarding documentation and comprehensive support channels are less explicit in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	D2P	ChestView US
Primary Use Case	Converts 2D medical imaging data (DICOM) into 3D digital anatomical models for advanced visualization, surgical planning, and 3D printing of patient-specific models.	AI-powered Computer-Assisted Detection (CADe) software for chest X-rays, assisting radiologists and emergency medicine physicians in detecting multiple pathologies and reducing reading times.
Supported Imaging Modalities	CT, MR, CBCT	Chest X-rays
Key Output/Functionality	3D digital anatomical models; DICOM viewer and analysis; Automatic and manual segmentation; VR visualization; 3D model editing tools; Export of 3D digital models in various file formats.	Detection and localization of pneumothorax, pleural effusion, consolidation, mediastinal/hilar mass, pulmonary nodule; Triage and worklist prioritization; Automatic Cardiothoracic Ratio (CTR) measurement; AutoReport generation.
Target Medical Specialties	Neurosurgery, Orthopedics, Radiology	Emergency Medicine, Radiology
Core AI/Automation Focus	Deep learning driven automatic and manual segmentation tools.	AI-powered Computer-Assisted Detection (CADe) for pathologies and worklist prioritization.

Videos

Demos, reviews, and walkthroughs featuring D2P and ChestView US.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do D2P and ChestView US integrate into distinct clinical workflows, and what are their primary clinical applications?

D2P is designed for advanced visualization and surgical planning, allowing physicians to convert 2D medical imaging data into patient-specific 3D anatomical models for pre-operative insight and 3D printing. ChestView US, conversely, acts as an AI copilot for radiologists and emergency physicians, integrating into chest X-ray reading workflows to assist in detecting multiple pathologies and prioritizing cases.

What is the expected depth of integration with existing EHR and PACS systems for each tool?

D2P primarily focuses on converting DICOM data and exporting 3D models in various formats, which can then be integrated into patient records or used in other software. ChestView US offers deeper integration by generating AutoReports and facilitating worklist prioritization, suggesting direct interaction with PACS and potentially RIS/EHR for diagnostic reporting and workflow management.

How do the accuracy and sensitivity claims of each tool translate into tangible clinical benefits for patient care?

D2P's focus on creating accurate 3D anatomical models directly supports enhanced surgical planning and patient education, potentially leading to improved surgical outcomes and reduced operative time. ChestView US's AI-powered detection of pathologies and triage capabilities aim to improve diagnostic accuracy, reduce missed findings, and expedite critical diagnoses in high-volume settings.

What is the typical learning curve for physicians to become proficient with each tool, and how quickly can a practice expect to realize its value?

D2P, with its advanced segmentation and 3D model editing tools, may involve a moderate learning curve for physicians to master the creation of complex anatomical models. ChestView US, as an AI-powered detection and reporting assistant, likely has a lower learning curve, allowing for quicker integration into daily workflows and a more rapid realization of value through improved efficiency and diagnostic support.

What audit-trail features are available to track the use and outputs of each tool for accountability and quality assurance?

For D2P, the process of converting 2D images to 3D models and subsequent editing steps would inherently create a traceable workflow for model generation. ChestView US provides AutoReport generation, which would include the AI's findings and contribute to a clear audit trail within the diagnostic reporting process, aiding in accountability and quality assurance.

What are the key considerations for implementing each tool across multiple clinical sites or a large hospital system?

D2P is described as a stand-alone, workstation-based software package, meaning each site would likely require individual installations and dedicated hardware. ChestView US offers more flexible deployment options, including cloud-based, dedicated local hardware, or virtualized environments, which could simplify multi-site rollouts and centralized management.